On Jul. 13, 2020, BioReference Laboratories, an OPKO Health company, announced that it would provide COVID-19 testing oversight for the National Basketball Association’s (NBA) players and referees, as well as team and league staff participating in the NBA’s 2020 season restart in Orlando.

Under the agreement with the NBA, BioReference will provide COVID-19 testing, which includes PCR diagnostics, rapid diagnostics and antibody testing.

The NBA and BioReference collaborated on testing protocols to provide the safest possible environment to restart the 2019-20 NBA season, going to extraordinary lengths to understand both the threats of the virus and the best means to control its spread. Testing protocols were established in consultation with infectious disease experts to ensure the safety of players and employees.